BASF Shareholders to Decide on Agribusiness Spin-Off Amid Geopolitical Crosswinds
Published on 04/15/2026 at 23:03 | Redaktion boerse-global.de
BASF shares have surged more than 18% since the start of the year, making the chemical giant one of the strongest performers in Germany's DAX index. The stock currently trades at around €53.69, just shy of its 52-week high of €54.70. This rally comes as the company navigates a complex mix of strategic progress and external market pressures.
The most significant strategic decision is now before shareholders. At the Annual General Meeting in Mannheim on April 30, investors will vote on the formal carve-out of the Agricultural Solutions division. Management plans to transfer the multi-billion-euro unit into a wholly-owned subsidiary, with the ultimate goal of an initial public offering on the Frankfurt Stock Exchange by 2027. This spin-off would fundamentally reshape the structure of the DAX-listed conglomerate.
Simultaneously, the company is advancing in its specialty chemicals business. At the in-cosmetics Global trade fair in Paris, BASF's Personal Care unit secured three awards, including one for its Aloversil ingredient derived from sea buckthorn press cake. The company also presented a new UV filter with a certified biomass balance. These high-margin specialty products offer more stable profitability than traditional bulk chemicals.
Should investors sell immediately? Or is it worth buying BASF?
However, geopolitical tensions are creating a challenging backdrop. According to the ifo Institute, nine out of ten German industrial companies are feeling the effects of the Iran conflict. For the chemical industry, the impact is twofold: oil is both an energy source and a key raw material. BASF has responded by announcing price increases of up to 30% for household and industrial cleaning products in Europe, citing raw material volatility, logistics costs, and energy prices.
Analysts are divided on how to interpret the situation. Deutsche Bank upgraded BASF to 'Buy' with a €55 price target, suggesting the company could benefit from Middle East uncertainty. Goldman Sachs reiterated its 'Buy' rating, raising its target to €63. In contrast, Kepler Cheuvreux downgraded the stock to 'Hold', arguing the thesis of BASF being a net beneficiary is overstated. Barclays maintains an 'Underweight' stance with the lowest active price target among major brokers.
Internally, the company's restructuring program is delivering results. BASF saved €1.7 billion in 2025, exceeding its target, and aims for an additional €2.3 billion in savings by 2026. The sale of a 60% stake in its coatings business for €7.7 billion has been completed, providing capital for the ongoing transformation.
Looking ahead, the company's management has issued a cautious forecast, expecting an EBITDA of no more than €7.0 billion for 2026, slightly below analyst expectations. The upcoming shareholder meeting on April 30 will also feature a vote on a proposed dividend of €2.25 per share and the release of first-quarter 2026 figures. Until then, developments in the Strait of Hormuz may influence the share price as much as any corporate announcement.
Ad
BASF Stock: New Analysis - 15 April
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
